Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Neurological and neuropsychiatric aspects of tuberous sclerosis complexLancet neurology, 2015-07, Vol.14 (7), p.733-745 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 2015 ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(15)00069-1 ;PMID: 26067126 ;CODEN: LANCAOFull text available |
2 |
Material Type: Article
|
![]() |
Tuberous sclerosisThe Lancet (British edition), 2008-08, Vol.372 (9639), p.657-668 [Peer Reviewed Journal]Elsevier Ltd ;2008 Elsevier Ltd ;2008 INIST-CNRS ;Copyright Elsevier Limited Aug 23-Aug 29, 2008 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)61279-9 ;PMID: 18722871 ;CODEN: LANCAOFull text available |
3 |
Material Type: Article
|
![]() |
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled studyThe Lancet (British edition), 2016-10, Vol.388 (10056), p.2153-2163 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 29, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31419-2 ;PMID: 27613521 ;CODEN: LANCAOFull text available |
4 |
Material Type: Article
|
![]() |
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialThe Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 12, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61134-9 ;PMID: 23158522 ;CODEN: LANCAOFull text available |
5 |
Material Type: Article
|
![]() |
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 studyThe lancet oncology, 2014-12, Vol.15 (13), p.1513-1520 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 2014 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(14)70489-9 ;PMID: 25456370 ;CODEN: LANCAOFull text available |